CytomX Therapeutics, Inc.
NASDAQ:CTMX
1.17 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -0.569 | -99.317 | -83.609 | -32.885 | -102.238 | -84.604 | -43.099 | -58.9 | -35.374 | -30.31 | -15.143 |
| Depreciation & Amortization
| 2.175 | 2.443 | 2.706 | 2.573 | 2.605 | 1.884 | 1.645 | 1.733 | 1.206 | 0.783 | 0.655 |
| Deferred Income Tax
| -31.128 | 0 | 0.272 | -0.236 | -2.228 | 0 | -0.513 | 0.006 | 0.008 | 0.008 | 0.01 |
| Stock Based Compensation
| 8.558 | 13.125 | 13.167 | 14.786 | 19.1 | 16.878 | 11.287 | 10.095 | 3.986 | 0.553 | 0.343 |
| Change In Working Capital
| -62.509 | -30.654 | -54.7 | 18.134 | -59.321 | -7.978 | 189.965 | 43.26 | -0.248 | 60.673 | 5.958 |
| Accounts Receivables
| 32.554 | -35.196 | 0.008 | -0.785 | 0.084 | 10.042 | -7.826 | -1.569 | 1.131 | -1.638 | -0.237 |
| Inventory
| 0 | 0 | 11.64 | -11.115 | -11.29 | 19.914 | 10.319 | -0.253 | 1.807 | 0.188 | 0.329 |
| Accounts Payables
| -1.426 | 0.068 | -0.139 | -0.857 | -0.374 | 0.261 | -2.441 | 1.765 | 2.944 | 0.66 | 0.366 |
| Other Working Capital
| -93.637 | 4.474 | -66.209 | 30.891 | -47.741 | -38.195 | 189.913 | 43.317 | -6.13 | 61.463 | 5.5 |
| Other Non Cash Items
| 27.438 | 3.615 | 3.133 | 2.887 | 1.602 | -1.701 | 11.088 | 1.774 | 3.007 | 0.095 | 0.169 |
| Operating Cash Flow
| -56.035 | -110.788 | -119.031 | 5.259 | -140.48 | -75.521 | 170.373 | -2.032 | -27.415 | 31.802 | -8.008 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -0.84 | -1.74 | -1.609 | -2.309 | -3.497 | -3.788 | -1.559 | -2.176 | -1.594 | -1.663 | -0.732 |
| Acquisitions Net
| 149.834 | 0 | -24.098 | 16.409 | -83.198 | -5.926 | 121.266 | 0.052 | 0 | 0 | 0 |
| Purchases Of Investments
| -424.834 | 0 | -99.898 | -199.108 | -174.992 | -204.601 | -218.707 | -121.517 | -250.901 | 0 | 0 |
| Sales Maturities Of Investments
| 275 | 100 | 123.996 | 182.699 | 258.19 | 214.315 | 99 | 169.5 | 122.75 | 0 | 0 |
| Other Investing Activites
| -149.834 | 100 | 24.098 | -16.409 | 83.198 | 5.926 | -121.266 | 0.052 | -0.817 | 0 | 0 |
| Investing Cash Flow
| -150.674 | 98.26 | 22.489 | -18.718 | 79.701 | 5.926 | -121.266 | 45.859 | -130.562 | -1.663 | -0.732 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.078 | -3.067 | -1.256 | -0.724 |
| Common Stock Issued
| 30.23 | 0.648 | 107.712 | 11.288 | 1.602 | 134.596 | 19.957 | 0.159 | 156.47 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.705 | 0 | 0 |
| Other Financing Activities
| 30.23 | 0.648 | 2.501 | 5.605 | 0.025 | 5.028 | 3.839 | 0.915 | 156.47 | 26.81 | 3.421 |
| Financing Cash Flow
| 30.23 | 0.648 | 110.213 | 16.893 | 1.627 | 139.624 | 23.796 | 0.996 | 153.403 | 25.554 | 2.697 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -176.479 | -11.88 | 13.671 | 3.434 | -59.152 | 70.029 | 72.903 | 44.823 | -4.574 | 55.693 | -6.043 |
| Cash At End Of Period
| 17.171 | 194.567 | 206.447 | 192.776 | 189.342 | 248.494 | 177.548 | 104.645 | 59.822 | 64.396 | 8.703 |